Based on the Neighbourly Pharmacy Inc stock forecast from 6 analysts, the average analyst target price for Neighbourly Pharmacy Inc is CAD 28.94 over the next 12 months. Neighbourly Pharmacy Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Neighbourly Pharmacy Inc is Bullish , which is based on 7 positive signals and 3 negative signals. At the last closing, Neighbourly Pharmacy Inc’s stock price was CAD 19.69. Neighbourly Pharmacy Inc’s stock price has changed by -4.97% over the past week, -8.08% over the past month and -31.87% over the last year.
No recent analyst target price found for Neighbourly Pharmacy Inc
No recent average analyst rating found for Neighbourly Pharmacy Inc
Company Overview
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies in 275 locations under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada. Read Less
Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies in 275 locations under the various banners, such as IDA/...Read More
Based on ratings from 6 analysts Neighbourly Pharmacy Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 5 buy, 1 sell and 2 hold ratings.
NBLY:CA stock's dividend yield is 0.91%.
Our analysis grades NBLY:CA stock's dividend yield at A+. This means that NBLY:CA stock's dividend yield
is above 100% of the stocks in the Pharmaceutical Retailers sector in the TSX exchange.
Based on this NBLY:CA may be a good dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for NBLY:CA is CAD 28.94 over the next 12 months. The maximum analyst target price is CAD 36 while the minimum anlayst target price is CAD 25.
NBLY:CA stock's Price/Earning ratio is 85.70.
Our analysis grades NBLY:CA stock's Price / Earning ratio at F. This means that NBLY:CA stock's Price/Earning ratio is above 50% of the stocks in the Pharmaceutical Retailers sector in the TSX exchange.
Based on this NBLY:CA may be fairly valued for its sector
The last closing price of NBLY:CA's stock was CAD 19.69.
The most recent market capitalization for NBLY:CA is CAD 0.88B.
Based on targets from 6 analysts, the average taret price for NBLY:CA is projected at CAD 28.94 over the next 12 months.
This means that NBLY:CA's stock price may go up by +47.00% over the next 12 months.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NBLY:CA !
Please login to proceed
Sorry - extended search is only available for registered users.
